UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
Matria Healthcare, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
576817209 (CUSIP Number) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
x Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
EXPLANATORY NOTE
This Schedule 13G is filed by Wells Fargo & Company on its own behalf and on behalf of any subsidiaries listed on Attachment A. Aggregate beneficial ownership reported by Wells Fargo & Company under Item 9 on page 2 is on a consolidated basis and includes any beneficial ownership separately reported herein by a subsidiary.
13G
1 | NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Wells Fargo & Company Tax Identification No. 41-0449260 |
|||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ |
|||
3 | SEC USE ONLY
|
|||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER
6 SHARED VOTING POWER
7 SOLE DISPOSITIVE POWER
8 SHARED DISPOSITIVE POWER
|
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
Not applicable |
|||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
Five percent or less |
|||
12 | TYPE OF REPORTING PERSON
HC |
2
13G
1 | NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Wells Capital Management Incorporated Federal ID No. 95-3692822 |
|||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ |
|||
3 | SEC USE ONLY
|
|||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
California |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER
6 SHARED VOTING POWER
7 SOLE DISPOSITIVE POWER
8 SHARED DISPOSITIVE POWER
|
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
Not applicable |
|||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
Five percent or less |
|||
12 | TYPE OF REPORTING PERSON
IA |
3
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
DISCLAIMER: Information in this Schedule 13G is provided solely for the purpose of complying with Sections 13(d) and 13(g) of the Act and regulations promulgated thereunder, and is not to be construed as an admission that Wells Fargo & Company or any of its subsidiaries is the beneficial owner of the securities covered by this Schedule 13G for any purpose whatsoever.
Item 1 |
(a) |
Name of Issuer: | ||||||||||
Matria Healthcare, Inc. | ||||||||||||
Item 1 |
(b) |
Address of Issuers Principal Executive Offices: | ||||||||||
1850 Parkway Place Marietta, GA 30067 |
||||||||||||
Item 2 |
(a) |
Name of Person Filing: | ||||||||||
Wells Fargo & Company Wells Capital Management Incorporated |
||||||||||||
Item 2 |
(b) |
Address of Principal Business Office or if none, Residence: | ||||||||||
1. Wells Fargo & Company 420 Montgomery Street San Francisco, CA 94104 |
||||||||||||
2. Wells Capital Management Incorporated 525 Market Street, 10th Floor San Francisco, CA 94105 |
||||||||||||
Item 2 |
(c) |
Citizenship: | ||||||||||
1. Wells Fargo & Company: Delaware
2. Wells Capital Management Incorporated: California |
||||||||||||
Item 2 |
(d) |
Title of Class of Securities: | ||||||||||
Common Stock | ||||||||||||
Item 2 |
(e) |
CUSIP Number: | ||||||||||
576817209 | ||||||||||||
Item 3 |
The person filing is a: | |||||||||||
1. Wells Fargo & Company: Parent Holding Company in accordance with 240.13d-1(b)(1)(ii)(G)
2. Wells Capital Management Incorporated: Registered Investment Advisor in accordance with Regulation 13d-1(b)(1)(ii)(E) |
4
Item 4 |
Ownership: | |||||||||
Not applicable. | ||||||||||
Item 5 |
Ownership of Five Percent or Less of a Class: | |||||||||
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x. | ||||||||||
Item 6 |
Ownership of More than Five Percent on Behalf of Another Person: | |||||||||
Not applicable. | ||||||||||
Item 7 |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: | |||||||||
See Attachment A | ||||||||||
Item 8 |
Identification and Classification of Members of the Group: | |||||||||
Not applicable. | ||||||||||
Item 9 |
Notice of Dissolution of Group: | |||||||||
Not applicable. | ||||||||||
Item 10 |
Certification: | |||||||||
Not applicable. |
5
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.
Date: June 14, 2005
WELLS FARGO & COMPANY
By: |
/s/ Laurel A. Holschuh | |
Laurel A. Holschuh, Senior Vice President and Secretary |
6
ATTACHMENT A
The Schedule 13G to which this attachment is appended is filed by Wells Fargo & Company on behalf of the following subsidiaries:
Wells Capital Management Incorporated (1)
Wells Fargo Bank, National Association (2)
Wells Fargo Fund Management, LLC (1)
(1) | Classified as a registered investment advisor in accordance with Regulation 13d-1(b)(1)(ii)(E). |
(2) | Classified as a bank in accordance with Regulation 13d-1(b)(1)(ii)(B). |
7